Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
From this trial, it cannot be concluded that one particular oral form is superior to the rest
Key Research Findings CAM Assay: BPC-157 increases blood vessel formation in chorioallantoic membrane models Wound Models: Enhanced angiogenesis observed in cutaneous wound healing studies VEGF Blockade: VEGF inhibitors (bevacizumab) partially block BPC-157's healing effects, confirming VEGF involvement L-NAME Studies: NOS inhibition reduces BPC-157 efficacy, confirming NO pathway involvement Potential Applications The angiogenic mechanism suggests utility in: Chronic Wounds: Diabetic ulcers and pressure sores with impaired healing Sports Injuries: Tendon, ligament, and muscle repair Post-Surgical: Accelerating anastomotic and incisional healing Ischemic Conditions: Enhancing blood supply to poorly perfused tissues Considerations Cancer Context: Angiogenesis is a concern in malignancy
Professor Guido Schoenenberger of the University of Basel, one of the key scientists to have worked on DSIP, disagreed
Beautiful place
Wondering why your friend pays $50 a month for a GLP-1 and you're quoted $500
